Veradermics Incorporated (MANE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | |
| Operating Expenses | 29,862 | 0 | 12,915 |
| Operating Income | -29,862 | N/A | -12,915 |
| Other Income | 2,630 | 0 | 515 |
| Pre-tax Income | -27,232 | 0 | -12,400 |
| Net Income Continuous | -27,232 | N/A | -12,400 |
| Net Income | $-27,232 | $N/A | $-12,400 |
| EPS Basic Total Ops | -1.32 | N/A | -19.79 |
| EPS Basic Continuous Ops | -1.20 | N/A | -16.83 |
| EPS Diluted Total Ops | -1.32 | N/A | -19.79 |
| EPS Diluted Continuous Ops | -1.20 | N/A | -16.83 |
| EBITDA(a) | $-29,862 | $N/A | $-12,915 |